ONCOMETHYLOME SCIENCES S A has a total of 23 patent applications. Its first patent ever was published in 2004. It filed its patents most often in Canada, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are SYNERGENZ BIOSCIENCE LTD, DIAMIR LLC and LEICA BIOSYSTEMS NEWCASTLE LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | Canada | 6 | |
#2 | WIPO (World Intellectual Property Organization) | 5 | |
#3 | EPO (European Patent Office) | 4 | |
#4 | United Kingdom | 4 | |
#5 | United States | 4 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Measuring microorganism processes | |
#2 | Therapeutic chemical compounds | |
#3 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Van Criekinge Wim | 7 |
#2 | Meijer Gerritt | 4 |
#3 | Van Der Zee Ate G J | 4 |
#4 | Van Der Zee Ate | 4 |
#5 | Straub Jozef | 4 |
#6 | De Carvalho Beatriz Pinto Morais | 4 |
#7 | Wisman Bea | 4 |
#8 | Dehaspe Luc | 3 |
#9 | Schuuring E M D | 3 |
#10 | Deregowski Valerie | 3 |
Publication | Filing date | Title |
---|---|---|
WO2011036173A1 | Detection and prognosis of cervical cancer | |
CA2718092A1 | Detection and prognosis of cervical cancer | |
EP2050828A2 | Methylation markers for early detection and prognosis of colon cancers | |
GB0700374D0 | NDRG family methylation markers | |
GB0609498D0 | Novel methylation marker | |
CA2604852A1 | Methylation markers for diagnosis and treatment of cancers | |
GB0515471D0 | Angiogenesis inhibition | |
WO2006007980A2 | Esr1 and cervical cancer | |
US2005118613A1 | Methods and kits for predicting the likelihood of successful treatment of cancer | |
GB0415988D0 | ESR1 and cervical cancer | |
WO2004087957A2 | Hypermethylated genes and cervical cancer |